Loring Wolcott & Coolidge Fiduciary Advisors’s Sarepta Therapeutics SRPT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-7	Closed	-$416	–	558
2025 Q1	$416	Hold	7	–	–	﹤0.01%	547
2024 Q4	$818	Sell	7 -19	-73%	-$2.22K	﹤0.01%	537
2024 Q3	$3.43K	Buy	+26	New	+$3.43K	﹤0.01%	536